ISN and NPG partner to create new journal

Share this article:
The International Society of Nephrology (ISN) has formed a partnership with Nature Publishing Group (NPG) to launch Nature Clinical Practice Nephrology in November 2005.
This partnership brings together the ISN's global network of over 20,000 nephrologists with NPG's successful publishing program, including its newest series of journals for practicing clinicians -- Nature Clinical Practice.
Former ISN President, Robert Schrier was named editor-in-chief.
Nature Clinical Practice Nephrology will provide the practicing physician with a comprehensive overview of the most up-to-date literature relevant to the diagnosis and management of patients with kidney disease. It will include editorial and opinion pieces, highlights from current literature, commentaries on the application of recent research to practical patient care, comprehensive reviews, and in-depth case studies.
Four journals in the Nature Clinical Practice series were launched last year; Nature Clinical Practice Nephrology and three other titles are planned for 2005. The series will eventually span some 14 titles.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Media


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Media

Five things for pharma marketers to know: Wednesday, October 22

Five things for pharma marketers to know: ...

Novo partners with YouTube star for diabetes vids; hedge fund wants Amgen to split up; J&J ramps up Ebola vaccine production.

Mucinex gets a revamp

Mucinex gets a revamp

After 10 years of "Mucinex In. Mucus Out," the congestion-relief treatment gets a new look from Reckitt Beckinser's recently appointed AOR McCann New York.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.